Teleflex (TFX) PT Rises To $408 At Needham After UroLift Drives Revenue and EPS Upside
Tweet Send to a Friend
Needham & Company analyst, Mike Matson, reiterated the Buy rating on shares of Teleflex (NYSE: TFX) and raised the price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE